Epilepsy — A Trial of Generic Substitution of Antiepileptic Drugs
Citation(s)
Andermann F, Duh MS, Gosselin A, Paradis PE Compulsory generic switching of antiepileptic drugs: high switchback rates to branded compounds compared with other drug classes. Epilepsia. 2007 Mar;48(3):464-9.
Bartoli A, Marchiselli R, Gatti G A rapid and specific assay for the determination of lamotrigine in human plasma by normal-phase HPLC. Ther Drug Monit. 1997 Feb;19(1):100-7.
Berg MJ, Gross RA, Haskins LS, Zingaro WM, Tomaszewski KJ Generic substitution in the treatment of epilepsy: patient and physician perceptions. Epilepsy Behav. 2008 Nov;13(4):693-9. doi: 10.1016/j.yebeh.2008.06.001. Epub 2008 Sep 10.
Bialer M, Midha KK Generic products of antiepileptic drugs: a perspective on bioequivalence and interchangeability. Epilepsia. 2010 Jun;51(6):941-50. doi: 10.1111/j.1528-1167.2010.02573.x. Epub 2010 Apr 8. Review.
Privitera MD Generic antiepileptic drugs: current controversies and future directions. Epilepsy Curr. 2008 Sep-Oct;8(5):113-7. doi: 10.1111/j.1535-7511.2008.00261.x.
Wilner AN Therapeutic equivalency of generic antiepileptic drugs: results of a survey. Epilepsy Behav. 2004 Dec;5(6):995-8.
Zachry WM 3rd, Doan QD, Clewell JD, Smith BJ Case-control analysis of ambulance, emergency room, or inpatient hospital events for epilepsy and antiepileptic drug formulation changes. Epilepsia. 2009 Mar;50(3):493-500. doi: 10.1111/j.1528-1167.2008.01703.x. Epub 2008 Jun 26.
A Randomized Controlled Trial of Generic Substitution of Antiepileptic Drugs
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
